Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 2014

View Archived Issues

Tumor profiling service could help determine optimal therapy for urothelial carcinoma

Scientists develop plant-derived immunogenic vaccine for atherosclerosis

Nuvo Research sells Pennsaid 2% U.S. rights to Horizon Pharma

Batu Biologics signs license agreement with UC San Diego

Results from the first study of fidaxomicin in pediatric patients with CDAD

Fispemifene licensed to Apricus Biosciences

HMB-45 staining increases after UVB treatment for vitiligo

Cystic fibrosis candidate N-6022 well tolerated in phase I study

First-in-human results on Novartis new antimalarial drug candidate

Takeda Pharmaceutical confirms U.S. launch of Contrave

Baxter launches Hyqvia in the U.S. for adults with primary immunodeficiency

NewLink Genetics enters into exclusive worldwide licensing agreement for NLG-919

FDA grants fast track designation to TAS-102 for refractory metastatic colorectal cancer

Matinas BioPharma submits IND for MAT-9001 for severe hypertriglyceridemia

Pharmacyclics files sNDA for Imbruvica for Waldenstrom's macroglobulinemia

FDA accepts for review a BLA for pediatric hexavalent vaccine

EMA grants orphan drug designation to isactuzumab govitecan

CK18 as a potential predictor of type 2 diabetes in patients with NAFLD

Taisho submits Japanese filing for esflurbiprofen patch for osteoarthritis

GLPG-1205 demonstrates good safety in a phase I study

TesoRx and Aspen sign license agreement for bio-identical oral testosterone replacement therapy

FDA advisory committee recommends approval of secukinumab for plaque psoriasis

FDA approves Xiaflex to treat up to two joints in Dupuytren's contracture

Ofev launched in U.S.

RegeneRx allowed to advance RGN-259 into phase III for neurotrophic keratopathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...